运动功能区脑病变患者的临床结局与导航经颅磁刺激特征的关联:导航经颅磁刺激联合弥散张量成像纤维追踪方法
研究分析86例高级别胶质瘤、低级别胶质瘤或颅内转移瘤患者的术前导航经颅磁刺激(nTMS)运动定位及基于nTMS的弥散张量成像纤维追踪(DTI FT)数据,在50%、75%、100%个体化FA阈值下测量病灶至皮质脊髓束(CST)的最小距离及重建CST纤维数,并与术前、术后及随访运动功能和静息运动阈值(rMT)相关。结果显示在特定FA水平下,高级别胶质瘤患者中无运动障碍者与发生手术相关一过性或永久性运动障碍者的病灶至CST距离存在统计学显著差异,且未观察到病灶至CST距离≥12 mm者出现新的手术相关永久性瘫痪。作者认为基于nTMS的DTI FT可能适用于高级别胶质瘤患者的个体化风险评估。
要点
- 高级别胶质瘤患者中,无运动障碍者与发生手术相关一过性或永久性运动障碍者在75% FAT(p=0.0149)和100% FAT(p=0.0233)下病灶至CST距离存在统计学显著差异。
- 在50% FAT和75% FAT下,未观察到病灶至CST距离≥12 mm的患者出现任何新的手术相关永久性瘫痪。
- 手术相关一过性瘫痪患者rMT与病灶至CST距离呈较强负相关(50% FAT:rs=-0.8660;75% FAT:rs=-0.8660),手术相关永久性瘫痪患者亦呈负相关(50% FAT:rs=-0.7656;75% FAT:rs=-0.6763)。
核心结论
- 作者认为,基于nTMS的DTI FT除作为手术规划工具外,可能适用于高级别胶质瘤患者的个体化风险评估。
- 作者指出,风险评估所需数据无需显著额外工作量即可获得,使该方法可能对直接临床使用有价值。
研究设计与样本
- 研究分析86例高级别胶质瘤、低级别胶质瘤或颅内转移瘤患者的术前nTMS运动定位及基于nTMS的皮质脊髓束DTI FT数据。
- 在个体化FA阈值(FAT)的50%、75%和100%水平进行纤维追踪,测量病灶至CST最小距离并评估重建CST纤维数。
- 将上述数据与术前、术后及随访运动功能状态和静息运动阈值进行相关性分析。
主要发现
- 在75% FAT(p=0.0149)和100% FAT(p=0.0233)下,高级别胶质瘤患者中无运动障碍者与发生手术相关一过性或永久性运动障碍者的病灶至CST距离存在统计学显著差异。
- 在50% FAT和75% FAT下,未观察到病灶至CST距离≥12 mm的患者出现任何新的手术相关永久性瘫痪。
- 手术相关一过性瘫痪患者的rMT与病灶至CST距离呈较强负相关(50% FAT:rs=-0.8660;75% FAT:rs=-0.8660)。
- 手术相关永久性瘫痪患者的rMT与病灶至CST距离呈较强负相关(50% FAT:rs=-0.7656;75% FAT:rs=-0.6763)。
关键数值与推荐
- 病灶至CST距离在75% FAT下无运动障碍者与手术相关一过性或永久性运动障碍者比较p=0.0149,在100% FAT下比较p=0.0233。
- 50% FAT和75% FAT下,病灶至CST距离≥12 mm的患者中未观察到新的手术相关永久性瘫痪。
- 手术相关一过性瘫痪患者rMT与病灶至CST距离的Spearman相关系数:50% FAT rs=-0.8660,75% FAT rs=-0.8660。
- 手术相关永久性瘫痪患者rMT与病灶至CST距离的Spearman相关系数:50% FAT rs=-0.7656,75% FAT rs=-0.6763。
临床怎么用
- 作者认为,基于nTMS的DTI FT可能适用于高级别胶质瘤患者的个体化风险评估,并可作为手术规划工具。
- 作者指出,风险评估所需数据无需显著额外工作量即可获得,使该方法可能对直接临床使用有价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Navigated transcranial magnetic stimulation (nTMS) and diffusion tensor imaging fiber tracking (DTI FT) based on nTMS data are increasingly used for preoperative planning and resection guidance in patients suffering from motor-eloquent brain tumors. The present study explores whether nTMS-based DTI FT can also be used for individual preoperative risk assessment regarding surgery-related motor impairment. METHODS Data derived from preoperative nTMS motor mapping and subsequent nTMS-based tractography in 86 patients were analyzed. All patients suffered from high-grade glioma (HGG), low-grade glioma (LGG), or intracranial metastasis (MET). In this context, nTMS-based DTI FT of the corticospinal tract (CST) was performed at a range of fractional anisotropy (FA) levels based on an individualized FA threshold ([FAT]; tracking with 50%, 75%, and 100% FAT), which was defined as the highest FA value allowing for visualization of fibers (100% FAT). Minimum lesion-to-CST distances were measured, and fiber numbers of the reconstructed CST were assessed. These data were then correlated with the preoperative, postoperative, and follow-up status of motor function and the resting motor threshold (rMT). RESULTS At certain FA levels, a statistically significant difference in lesion-to-CST distances was observed between patients with HGG who had no impairment and those who developed surgery-related transient or permanent motor deficits (75% FAT: p = 0.0149; 100% FAT: p = 0.0233). In this context, no patient with a lesion-to-CST distance ≥ 12 mm suffered from any new surgery-related permanent paresis (50% FAT and 75% FAT). Furthermore, comparatively strong negative correlations were observed between the rMT and lesion-to-CST distances of patients with surgery-related transient paresis (Spearman correlation coefficient [rs]; 50% FAT: rs = -0.8660; 75% FAT: rs = -0.8660) or surgery-related permanent paresis (50% FAT: rs = -0.7656; 75% FAT: rs = -0.6763). CONCLUSIONS This is one of the first studies to show a direct correlation between imaging, clinical status, and neurophysiological markers for the integrity of the motor system in patients with brain tumors. The findings suggest that nTMS-based DTI FT might be suitable for individual risk assessment in patients with HGG, in addition to being a surgery-planning tool. Importantly, necessary data for risk assessment were obtained without significant additional efforts, making this approach potentially valuable for direct clinical use.
引用
- Sollmann N, Wildschuetz N, Kelm A, et al. Associations between clinical outcome and navigated transcranial magnetic stimulation characteristics in patients with motor-eloquent brain lesions: a combined navigated transcranial magnetic stimulation-diffusion tensor imaging fiber tracking approach. J Neurosurg. 2017. PMID: 28362239. doi:10.3171/2016.11.JNS162322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。